We observed a neonate who had severe thrombocytopenia wherein evaluations for neonatal immune-mediated thrombocytopenia and congenital infections were negative, and the marrow findings were consistent with congenital amegakaryocytic thrombocytopenia (CAMT). A genomic microarray identified a microdeletion at 21q22.11 including the gene RUNX1. Two somewhat similar cases were recently reported, but with multiple congenital anomalies that are not present in our case. We propose that a 21q22 deletion resulting in RUNX1 haploinsufficiency can produce a phenotype similar to CAMT with various associated anomalies depending on which adjacent genes are absent or disrupted.
Introduction
When severe thrombocytopenia is detected in a healthy-appearing term newborn infant, neonatal alloimmune thrombocytopenia is likely, although a wide variety of other possibilities also exist. 1, 2 An elevated mean platelet volume (MPV) is common in immune-mediated neonatal thrombocytopenias, as well as in other consumptive thrombocytopenias, on the basis of accelerated platelet production accompanying the platelet destruction. 3 We evaluated a term neonate with severe thrombocytopenia and a normal MPV. Studies excluded neonatal alloimmune thrombocytopenia, TORCH (toxoplasmosis, other, rubella, cytomegalovirus, herpes simplex) infections and bacterial sepsis, and a marrow aspirate was consistent with congenital amegakaryocytic thrombocytopenia (CAMT). Genomic microarray identified a constitutional microdeletion on chromosome 21q22.11 involving RUNX1, a gene in which certain mutations are known to give rise to familial thrombocytopenia.
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Case
The neonate was delivered vaginally at 39 and 5/7 weeks gestation to a married 24-year-old healthy, rubella-immune, HIV-negative, GBS-negative, Caucasian mother with no consanguinity and no family history of thrombocytopenia. Apgar scores were 7 and 9 (at 1 and 5 min). Birth weight was 2523 g (3rd percentile), length 47 cm (3rd percentile) and OFC (occipital-frontal circumference) 34 cm (10th percentile). The head, eyes, ears and nose appeared normal. The anterior fontanel was open, soft and flat. Mild respiratory distress was noted and supplemental oxygen (40%) was administered by a head-box. A wide-spread petechial rash was noted, prompting a platelet count, which was 9000 ml À1 with an MPV of 8.5 fl. The remaining elements of the CBC were all within the reference range for age. 9 Because of severe thrombocytopenia the neonate was transported to a tertiary-care NICU (neonatal intensive care unit).
On arrival at the NICU he had no apparent distress or obvious malformations other than symmetrical growth retardation and a widespread petechial rash without bruising, His hands and forearms appeared normal. Intravenous antibiotics were administered with the suspicion of bacterial infection. Supplemental oxygen administration was not needed after the first few hours. Over the first 3 days the blood culture was sterile and antibiotic treatment was stopped. A urine culture for cytomegalovirus was negative, as were rapid diagnostic tests for herpes simplex and titers for toxoplasmosis, cytomegalovirus, rubella and herpes. An echocardiogram was normal, as was a head ultrasound study.
The platelet count remained <10 000 ml À1 with a normal MPV (range 8.5-10.0 fl), and platelet transfusions (random singledonor, irradiated and leukoreduced, 15 ml kg À1 ) were administered on days 2 and 14, each resulting in a rise in platelet count by an increment >50 000 ml À1 with a gradual drop to pre-transfusion values in 3-4 days. The maternal antiplatelet antibody panel was negative. Blood films were consistent with the automated platelet count, showing scanty normal-size platelets with normal morphology. No studies of platelet function were performed. A bone marrow aspirate obtained from the tibia on day of life 18 was cellular and adequate for evaluation. The full spectrum of erythroid and myeloid maturation was present with no dyspoietic features. After extensive scanning, only a very rare megakaryocyte was identified, with normal nuclear lobulation and cytoplasmic granularity.
On day of life 9, whole-genome chromosomal microarray analysis was performed using Affymetrix methodology and software (Genotyping Console and Chromosome Analysis Suite, Affymetrix, Santa Clara, CA, USA). The array includes over 2.1 Â 10 6 markers across the entire genome. A microdeletion was identified on chromosome 21 involving a 3.1-Mb segment from 21q22.11 to 21q22.12, indicating partial monosomy for this region. The deleted area includes RUNX1 (previously implicated in thrombocytopenia), CLIC6, RCAN1 and ITSN (previously implicated in mental retardation) 10 and KCNE1 (previously implicated in cardiomyopathy).
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A brain magnetic resonance imaging study was performed on day of life 14 because of poor nipple feeding. It was interpreted as a normal structure but possibly containing scattered foci of pinpoint hemorrhages. He was seen by a pediatric ophthalmologist, who found no abnormalities. He failed a bed-side hearing screen and subsequently failed auditory brainstem response testing twice, with a pattern consistent with abnormal central conduction of acoustic stimuli, more abnormal on the right than left. At the time of discharge to home, on day of life 27, he was still not nipple feeding well, requiring gavage feedings for about 20% of the daily feeding volume and he had bilateral inguinal hernias. At discharge, he had a platelet count of 75 000 ml À1 and an MPV of 9.7 fl. At the age of 2 months he was re-hospitalized for herniorrhaphy under general endotracheal anesthesia for large bilaterial inguinal hernias. He received a platelet transfusion before surgery with no excessive bleeding during or after surgery. Mild hip dysplasia was noted incidentally on an abdominal X-ray during that hospitalization. He was seen in our pediatric hematology clinic at the second and fourth months. His developmental milestones were delayed; weight gain had been poor (average 11 g per day), he had severe head-lag, and was reported as being very fussy. He had obvious severe nipple aversion and was taking almost all feedings through a nasogastric tube. The platelet count was 56 000 ml À1 , and MPV was 9.6 fl.
Discussion
Alloimmune neonatal thrombocytopenia is a relatively common diagnosis among neonates who have severe thrombocytopenia but otherwise appear well. [1] [2] [3] Maternal autoimmune disorders can also result in neonatal thrombocytopenia, but the platelet counts are not usually as low as in our present case. However, in the patient we report, the normal MPV, the adequate initial response to random-donor platelet transfusions and the ability to sustain that response for a few days, together with the absence of maternal antiplatelet antibody, made the more common immune etiologies very unlikely. Also atypical for neonatal alloimmune thrombocytopenia in our patient were his symmetrical intrauterine growth retardation, hearing deficits, inguinal hernias and poor nipple feedings.
CAMT (OMIM no. 604498), a rare marrow-failure syndrome, presents with thrombocytopenia and a marrow aspirate, similar to that of our patient, with absent or few megakaryocytes but normal erythroid and granulocytic elements. 12, 13 Most neonates with CAMT have no other congenital malformations, and are found to have homozygous or compound heterozygous mutations in the thrombopoietin receptor gene c-MPL located on chromosome 1.
12,13 However, not all neonates with a CAMT phenotype have a c-MPL mutation. In fact Geddis 13 reported that some neonates classified as having CAMT have no known mutation, and that some of these patients have minor dysmorphic features. We speculate that the patient we report is one such, and could be classified as having a subtype of CAMT due to a de novo microdeletion involving RUNX1 and surrounding genes. Perhaps these surrounding genes are involved in the symmetric growth retardation, hearing deficits, hernias and poor feeding.
Katzaki et al.
14 from Siena recently reviewed 12 children with syndromic thrombocytopenia and mental retardation with microdeletions in the 21q22.11 region. Also, Click et al. 15 from Seattle recently reported on a newborn infant with a deletion in this area who presented with thrombocytopenia and multiple congenital anomalies including Tetralogy of Fallot, anemia and developmental delay. Melis et al. 16 recently described the case of a 3-year-old with complex congenital heart disease, thrombocytopenia and mental retardation with a chromosome 21 pericentric inversion where RUNX1 was not deleted but they hypothesized that its regulatory regions were disrupted.
The mechanistic explanation for thrombocytopenia in patients who are haploinsufficient for RUNX1 is not completely clear. Aneia et al. 17 demonstrated that RUNX1 is a transcriptional regulator of platelet factor 4 (an abundant protein stored in platelet alpha-granules). Jalagadugula et al. 18 demonstrated that platelet myosin light chain is a direct target of RUNX1. Therefore deficiency of RUNX1 mRNA in megakaryocytes could adversely affect platelet production in a number of ways.
The MPV can be a simple means of classifying neonatal thrombocytopenias; 19 small platelets in a male suggest WASP mutations at Xp11.23 giving rise to Wiscott-Aldrich syndrome (OMIM no. 300392) or X-linked thrombocytopenia (OMIM no. 313900). Very large platelets are often the result of accelerated platelet destruction as in neonatal alloimmune thrombocytopenia, but are also seen in various familial thrombocytopenia syndromes such as Bernard Soulier (OMIM no. 231200), the MYH9-related disorder (OMIM no. 600208) and von Willebrand disease type IIB. Normal-size platelets are typical of CAMT and RUNX1 mutations, and are also found in those with obvious orthopedic malformations of the arms such as TAR (thrombocytopenia and absent radii) and ATRUS (amegakaryocytic thrombocytopenia with radio-ulnar synostosis). 20 Severe thrombocytopenia is not an uncommon problem in neonatology practice. 21 Although most such cases are acquired varieties of consumptive thrombocytopenia with an obvious cause, a few are congenital and puzzling. On the basis of our present report and a growing number of somewhat similar cases, [14] [15] [16] we propose that when congenital thrombocytopenia is observed in a neonate who has malformations not involving the arms (TAR or ATRUS), and the MPV is normal, microdeletions in 21q, including the gene RUNX1, should be a prime consideration. As other cases with 21q microdeletions are recognized, a correlation between the dysmorphic features observed and the exact genes deleted or disrupted can lead to discovery of the function of some of these genes.
